Overall rank by patents
#3,166
Across all tracked assignees
USPTO PatentsView assignee record - 119 granted patents across 22 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Titan holds 119 US patents across 22 technology areas, rank #3,166 of 50,000 tracked assignees.
Titan Medical Inc. has been granted 119 US utility patents between 2015 and 2025, placing Titan Medical Inc. at rank #3,166 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Titan Medical Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Titan sits between Rolls-royce High Temperature Composites, Inc. (119 patents, rank #3,162) and ZURN Industries, Llc (119 patents, rank #3,170) - the closest US assignees by grant volume. The composite Innovation Score of 51.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 95 grants, compared with 24 in the 2015–2019 window, a +296% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Titan Medical Inc.'s 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Titan Medical Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Rolls-Royce High Temperature Composites, Inc.
119 patents
SUZHOU METABRAIN INTELLIGENT TECHNOLOGY CO., LTD.
119 patents
Swisscom AG
119 patents
Telebrands Corp.
119 patents
Verizon Digital Media Services Inc.
119 patents
Wyse Technology L.L.C.
119 patents
YAMABIKO CORPORATION
119 patents
ZURN INDUSTRIES, LLC
119 patents
Titan Medical Inc.
119 patents
What this shows Titan holds 119 patents at rank #3,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,166 in granted patent volume.
Other assignees with the most granted patents in Titan's primary technology class.
Titan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 2.5% |
| 2016 | 1 | 0.8% |
| 2017 | 4 | 3.4% |
| 2018 | 4 | 3.4% |
| 2019 | 12 | 10.1% |
| 2020 | 16 | 13.4% |
| 2021 | 26 | 21.8% |
| 2022 | 17 | 14.3% |
| 2023 | 23 | 19.3% |
| 2024 | 12 | 10.1% |
| 2025 | 1 | 0.8% |
Top 15 of 22 technology areas
Overall rank by patents
#3,166
Across all tracked assignees
51.0 out of 100
How to use this portfolio
Titan's 119 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.